Oramed Pharmaceuticals (ORMP) Cash & Equivalents Growth (5y) (2015 - 2021)
Oramed Pharmaceuticals (ORMP) Cash & Equivalents Growth (5y) (2015 - 2021) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Oramed Pharmaceuticals |
151.47 Mn |
133.31 Mn |
- |
| Date | Value |
|---|
| Nov 30, 2021 |
69.33% |
| Aug 31, 2021 |
81.64% |
| May 31, 2021 |
77.03% |
| Feb 28, 2021 |
59.94% |
| Nov 30, 2020 |
50.26% |
| Aug 31, 2020 |
43.12% |
| May 31, 2020 |
19.34% |
| Feb 29, 2020 |
40.03% |
| Nov 30, 2019 |
-13.78% |
| Aug 31, 2019 |
13.57% |
| May 31, 2019 |
9.78% |
| Feb 28, 2019 |
192.56% |
| Nov 30, 2018 |
199.58% |
| Aug 31, 2018 |
17.07% |
| May 31, 2018 |
27.16% |
| Feb 28, 2018 |
10.06% |
| Nov 30, 2017 |
-25.63% |
| Aug 31, 2017 |
-2.18% |
| May 31, 2017 |
5.92% |
| Feb 28, 2017 |
-4.46% |
